SNDX
NASDAQ · Biotechnology
Syndax Pharmaceuticals Inc
$9.55
+0.18 (+1.92%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Price Target
Analyst Price Target
+156.4% upside
Low Target
$15.15
Average Target
$24.49
High Target
$32.88
Current Price
$9.55
Current
$9.55
$9.55
Target
$24.49
$24.49
$15.15
$24.49 avg
$32.88
Scenario Analysis
Bear Case
$15.15
58.6%
Low target
Base Case
$24.49
+156.4%
Avg target
Bull Case
$32.88
+244.3%
High target
Risk/Reward
4.2x
Highly favorable
Price in Context
52-Week High
$25.59
-62.7% from high
52-Week Low
$9.29
+2.8% from low
50-Day SMA
$16.33
-41.5% vs SMA
200-Day SMA
$20.00
-52.3% vs SMA
RSI (14)
31.6
Neutral
Target vs 52W High
$24.49
-4.3% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |